Regencell Bioscience Holdings (Regencell Bioscience Holdings) Accumulated other comprehensive income (loss)

: $-0.09 Mil (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Regencell Bioscience Holdings's Accumulated other comprehensive income (loss) for the quarter that ended in Jun. 2023 was $-0.09 Mil.

Regencell Bioscience Holdings's quarterly Accumulated other comprehensive income (loss) stayed the same from Jun. 2022 ($0.00 Mil) to Dec. 2022 ($0.00 Mil) but then declined from Dec. 2022 ($0.00 Mil) to Jun. 2023 ($-0.09 Mil).

Regencell Bioscience Holdings's annual Accumulated other comprehensive income (loss) stayed the same from Jun. 2021 ($0.00 Mil) to Jun. 2022 ($0.00 Mil) but then declined from Jun. 2022 ($0.00 Mil) to Jun. 2023 ($-0.09 Mil).

Regencell Bioscience Holdings Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Regencell Bioscience Holdings's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regencell Bioscience Holdings Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

Accumulated other comprehensive income (loss)

-0.09

Regencell Bioscience Holdings Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Accumulated other comprehensive income (loss)					-	-	-	-	-0.09

Regencell Bioscience Holdings Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Regencell Bioscience Holdings Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Regencell Bioscience Holdings's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Regencell Bioscience Holdings (Regencell Bioscience Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Regencell Bioscience Holdings Ltd (NAS:RGC) » Definitions » Accumulated other comprehensive income (loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

29 Leighton Road, 9/F Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG

Website

https://www.regencellbioscience.com

Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.